发明名称 Modified polynucleotides for the production of biologics and proteins associated with human disease
摘要 The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
申请公布号 US8999380(B2) 申请公布日期 2015.04.07
申请号 US201313791922 申请日期 2013.03.09
申请人 Moderna Therapeutics, Inc. 发明人 Bancel Stephane;Chakraborty Tirtha;de Fougerolles Antonin;Elbashir Sayda M.;John Matthias;Roy Atanu;Whoriskey Susan;Wood Kristy M.;Hatala Paul;Schrum Jason P.;Ejebe Kenechi;Ellsworth Jeff Lynn;Guild Justin
分类号 C12N15/85;A61K38/17;C07K14/47;C07K14/62;A61K48/00;A61K31/7115;C12N9/88;A61K9/127;C12N15/11;C07K14/705;C07K14/505;C07K14/535;C12N9/64;C12N9/10;C12N9/00;C12N9/42;C12N15/87;C12P13/04;A61K38/45;C07K14/005;C12N9/16;C12N9/24;C12N15/52;C07K14/435;C12P21/00;A61K38/00 主分类号 C12N15/85
代理机构 DT Ward PC 代理人 DT Ward PC ;Ward Donna T.;Bryan Jennifer F.
主权项 1. An isolated polynucleotide comprising; (a) a first region of linked nucleosides, said first region encoding a polypeptide of interest, said polypeptide of interest is SEQ ID NO: 1089; (b) a first flanking region located at the 5′ terminus of said first region comprising at least one 5′ terminal cap; (c) a second flanking region located at the 3′ terminus of said first region comprising a 3′ tailing sequence of linked nucleosides; andwherein at least one of said linked nucleosides of (a) comprises at least one modification as compared to the chemical structure of an A, G, U or C ribonucleoside.
地址 Cambridge MA US
您可能感兴趣的专利